19 May 2022 | News
Inks new partnership with CEPI
image credit- shutterstock
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Japan-based Global Health Innovative Technology Fund (GHIT) have announced the signing of a Memorandum of Understanding (MoU) which will strengthen collaboration between the two organizations as they work to advance the development of tools to fight infectious diseases.
CEPI and GHIT have aligned mandates, with both agencies funding equitable-access focused research and development for medical countermeasures. This new collaboration will support both organizations to deliver their respective missions by enabling them to draw on each other’s comparative strengths and areas of expertise in the field of vaccine development, as well as other areas where mutual benefits have been identified. The partnership also aims to enhance vaccine and therapeutic development capabilities in Japan, furthering Japan’s participation in global efforts to counter the threats of infectious diseases.
The partners will now plan opportunities for practical cooperation in more detail including strengthening both organizations’ investment portfolios by jointly identifying promising vaccine development platforms and technologies and collaborating (to include potential co-funding or coordinated funding) on vaccine R&D for priority pathogens and virus families of mutual interest.